Wiley Matthew T. 4
4 · VYNE Therapeutics Inc. · Filed Jul 2, 2021
Insider Transaction Report
Form 4
Wiley Matthew T.
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2021-06-30$3.51/sh−5,151$18,080→ 109,246 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.